BMS-794833

Modify Date: 2026-08-06 17:16:59

BMS-794833 Structure
BMS-794833 structure
Common Name BMS-794833
CAS Number 1174046-72-0 Molecular Weight 468.840
Density 1.5±0.1 g/cm3 Boiling Point 637.2±55.0 °C at 760 mmHg
Molecular Formula C23H15ClF2N4O3 Melting Point N/A
MSDS N/A Flash Point 339.2±31.5 °C

 Use of BMS-794833


BMS-794833 is a VEGFR2 and Met inhibitor extracted from patent WO2009094417, compound example 1; has IC50s of 15 and 1.7 nM, respectively.

 Names

Name N-[4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl]-5-(4-fluorophenyl)-4-oxo-1H-pyridine-3-carboxamide
Synonym More Synonyms

 BMS-794833 Biological Activity

Description BMS-794833 is a VEGFR2 and Met inhibitor extracted from patent WO2009094417, compound example 1; has IC50s of 15 and 1.7 nM, respectively.
Related Catalog
Target

VEGFR2:15 nM (IC50)

Met:1.7 nM (IC50)

In Vitro BMS794833 inhibits Met receptor activated gastric carcinoma cell line, GTL-16, with an IC50 of 39 nM[1].
In Vivo BMS-794833 is active by greater than 50% tumor growth inhibition for at least one tumor doubling time in the GTL-16 gastric carcinoma model. No toxicity is observed at any of the dose levels when administered once daily for a duration of 14 days[1].
Cell Assay GTL-16 cells are inoculated in to 96 well microtiter plates in 0.5% fetal calf serum and incubated at 37°C, 5% CO2, 95% air and 100% relative humidity for 24 h prior to addition of a compound. Cells are treated with BMS-794833 for an additional 72 h. Growth inhibition is calculated[1].
References

[1]. WO2009094417

 Chemical & Physical Properties

Density 1.5±0.1 g/cm3
Boiling Point 637.2±55.0 °C at 760 mmHg
Molecular Formula C23H15ClF2N4O3
Molecular Weight 468.840
Flash Point 339.2±31.5 °C
Exact Mass 468.080078
PSA 114.32000
LogP 4.26
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.681
Storage condition -20℃

 BMS-794833Bioassay

View more

Name: Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident pro...
Source: NCGC
Target: N/A
External Id: SERCaMPGLuc-p1-antagonist
Name: Primary qHTS assay for inhibitors of alpha-synuclein gene (SNCA) expression
Source: NCGC
External Id: SNCA-p-activity-luciferase
Name: Primary qHTS for Identification of Small Molecule Activators of Huntingtin-Antisense ...
Source: NCGC
External Id: huntington-HTTAS8-p1-FF-overN
Name: Cytotoxicity counterscreen for inhibitors of SARS-CoV-2 cell entry
Source: NCGC
Target: N/A
External Id: TRND-SARS-CoV-2-cytotox-48hr
Name: Primary qHTS to identify inhibitors of SARS-CoV-2 cell entry
Source: NCGC
External Id: TRND-SARS-CoV-2-PP
Name: Quantitative High-Throughput drug screen in 47 multiple myeloma cell lines against th...
Source: NCGC
Target: N/A
External Id: s-my-keats_OPM1-m4-1
Total 133, Current Page 1 of 14
1
2
3
4
5

 Synonyms

N-{4-[(2-Amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl}-5-(4-fluorophenyl)-4-oxo-1,4-dihydro-3-pyridinecarboxamide
BMS-794833
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.